Look up a license
Match the name or license number. Check status, expiration, and any restrictions shown.
License Verification Covers: Maryland Board of Pharmacy.Maryland Board of Pharmacy
Maryland pharmacists need 30 hours of continuing education every 2 years. 2 state-mandated topics may apply, depending on the license and practice.
At a glance
| Licenses covered | Pharmacist (RPh) [1] |
|---|---|
| CE required for renewal | Yes [1] |
| Hours per CE period | 30 hours [1] |
| CE period | Every 2 years [1] |
| Renewal and reporting | Pharmacists applying for renewal must earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date. [1] |
| State-mandated topics | Preventing medication errors; Live instruction [1] |
| What CE counts | Approved continuing education providers include the Accreditation Council for Pharmacy Education (ACPE), ACPE-accredited schools of pharmacy, the FDA, the DEA, and Board-approved providers. [2] |
This summary covers the licenses listed above. The topics below are selected verified requirements; consult the board’s full rules for all subjects and conditions.
At least 1 hour must be on the topic of preventing medication errors, such as appropriate dispensing of opioids.
At least 2 CE hours must be obtained through live instruction.
Rules change, and your own license record decides your deadline. Confirm with the Maryland Board of Pharmacy ↗ before you renew.
Your next step
Match the name or license number. Check status, expiration, and any restrictions shown.
License Verification Covers: Maryland Board of Pharmacy.A public search may be enough for a status check. Another board or employer may require a verification sent directly by the issuer.
Check verification instructions Confirm the recipient’s required format and any fee.Confirm your due date, complete the required education, and submit to the licensing authority.
Online Renewal Covers: Maryland Board of Pharmacy.| Credential | Pharmacist |
|---|---|
| Renewal cycle | Confirm the cycle and expiration date for your specific license with the board. |
| Verified fees | A current fee has not been confirmed in this guide. Check the board’s fee schedule before paying. |
| Renewal application | Online Renewal |
Fees can differ for active, inactive, late, and reinstatement applications. Your official license record controls your deadline.
Dates show when we retrieved the source pages. They do not certify a person’s license, guarantee a portal is online, or establish that every renewal rule was reviewed.
Free courses that count toward the hours
The board accepts continuing education accredited by ACPE [2]. These current free courses state that accreditation. State-mandated topics can require a specific approved course, so check those separately.
The pace at which targetable tumor-specific molecular alterations have been identified over the past decade have ushered in an era of precision oncology, yielding significant insights into the diversity of cancer, offering diagnostic and prognostic benefits, and guiding therapy selection. Indeed, guidelines emphasize that comprehensive biomarker testing should be conducted to identify actionable mutations in non-small-cell lung cancer (NSCLC), including ALK, EGFR, KRAS, MET, RET, and ERBB2 (HER2). These tests guide the selection of targeted therapies that can inhibit oncogenic pathways directl
The management of type 2 diabetes (T2D) is complex, requiring a multidisciplinary, patient-centered approach that accounts for individualized glycemic and weight goals, comorbidities, hypoglycemia risk, medication costs, and individual preferences. Therapeutic inertia and patient reluctance often delay insulin initiation and intensification in patients with persistent hyperglycemia despite multiple antihyperglycemic agents. The emergence of once-weekly basal insulin analogues represent a transformative advancement in T2D management, offering a simplified treatment paradigm to address common ba
The management of hormone receptor–positive (HR-positive), human epidermal growth factor receptor 2–negative (HER2-negative) metastatic breast cancer (mBC) is undergoing rapid transformation, largely driven by the imperative to overcome acquired endocrine resistance, frequently mediated by somatic estrogen receptor 1 (ESR1) mutations. These mutations predict a lack of benefit from further aromatase inhibitor (AI) therapy, making the correct identification and subsequent targeting of these alterations critical for guiding treatment selection. Next-generation oral selective estrogen receptor deg
Selecting, intensifying, sequencing, or combining therapies in IBD can be challenging for clinicians, especially considering the number of novel targeted therapies available and the expanding role of patient-reported outcomes in individualization of therapeutic decision-making. Advance your IBD management through implementation of recommended treat-to-target strategies. Start with an individualized assessment to determine the strengths and gaps in your current practice, then review educational content according to your needs. Reinforce your learning through practical guidance (eg, interactive
a statement of participation Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry as well as pharmacists who are involved in the management of patients with treatment-resistant depression (TRD). Program Overview Treatment-resistant depression (TRD) presents ongoing challenges for psychiatric clinicians, including delayed recognition, trial-and-error treatment sequencing, and high relapse rates
a statement of participation. Target Audience The intended audience for this activity is physicians and nurse practitioners specializing in psychiatry, as well as pharmacists who are involved in the management of patients with anxiety and/or depression. Program Overview Several psychedelic and psychedelic-adjacent therapies are advancing through late-stage clinical development, expanding the evidence base supporting their efficacy in the management of anxiety a
Health 2.0: Implications for Care. A no-cost NetCE course from the reviewed profession catalog free sections.
2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care. A continuing education activity offered by Pharmacy Times Continuing Education.
A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension. A continuing education activity offered by Pharmacy Times Continuing Education.
Your next credential
Explore Maryland and national exam practice for your profession on OpenExamPrep.
These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.
Questions
Maryland pharmacists need 30 hours of continuing education every 2 years. 2 state-mandated topics may apply, depending on the license and practice. Pharmacists applying for renewal must earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date.
Preventing medication errors (1 hours): At least 1 hour must be on the topic of preventing medication errors, such as appropriate dispensing of opioids. Live instruction (2 hours): At least 2 CE hours must be obtained through live instruction.
Approved continuing education providers include the Accreditation Council for Pharmacy Education (ACPE), ACPE-accredited schools of pharmacy, the FDA, the DEA, and Board-approved providers. Free courses accredited by ACPE are listed on this page; a state-mandated topic may need a specific approved course.
Every fact above links to the official page it comes from. We fetched each page on the date shown and confirmed the exact wording below appears on it.
“practice in Maryland applying for renewal shall: (a) Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction;”
“practice in Maryland applying for renewal shall: (a) Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction;”
“practice in Maryland applying for renewal shall: (a) Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction;”
“practice in Maryland applying for renewal shall: (a) Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction;”
“practice in Maryland applying for renewal shall: (a) Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction;”
“the license expiration date that include: (i) 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction; (b) Attest to the fact that the pharmacist has completed the CE requirement on a Board approved form;”
“as appropriate dispensing of opioids; and (ii) 2 hours of CE obtained through live instruction; (b) Attest to the fact that the pharmacist has completed the CE requirement on a Board approved form; and (c) Retain supporting documents for inspection by the”
“2 hours of CE obtained through live instruction; (b) Attest to the fact that the pharmacist has completed the CE requirement on a Board approved form; and (c) Retain supporting documents for inspectio”
“qualify for continuing education (CE) credit: (1) American Council on Pharmaceutical Education (ACPE); (2) Schools of pharmacy accredited by ACPE; (3) Food and Drug Administration (FDA); (4) Drug Enforcement Administration (DEA); and (5) Additional providers of”